Maximillian Woodall

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Christopher Butler, Richard Hobbs, Oghenekome Gbinigie et al. · The Lancet · 2022 · 391 citations · Full text

Long Covid, Treatment And Prevention, Covid-19 Pandemic +9

Human SARS-CoV-2 challenge uncovers local and systemic response dynamics

Rik G.H. Lindeboom, Kaylee B. Worlock, Lisa M. Dratva et al. · Nature · 2024 · 102 citations · Full text

E-cigarette constituents propylene glycol and vegetable glycerin decrease glucose uptake and its metabolism in airway epithelial cells in vitro

Maximillian Woodall, J. J. Ochieng’ Konyango JACOB, Kameljit Kalsi et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 2020 · 74 citations · Full text

Age-specific nasal epithelial responses to SARS-CoV-2 infection

Maximillian Woodall, Ana-Maria Cujba, Kaylee B. Worlock et al. · Nature Microbiology · 2024 · 43 citations · Full text

Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients

Joseph F. Standing, Laura Buggiotti, José Afonso Guerra‐Assunção et al. · Nature Communications · 2024 · 38 citations · Full text